Macrovascular disease and systemic sclerosis

被引:125
作者
Ho, ML [1 ]
Veale, D
Eastmond, C
Nuki, G
Belch, J
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland
[2] Aberdeen Royal Infirm, Dept Rheumatol, Aberdeen, Scotland
[3] Univ Edinburgh, Western Gen Hosp, Dept Med, Rheumat Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1136/ard.59.1.39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To determine if macrovascular disease is more prevalent in systemic sclerosis (SSc) compared with unaffected subjects. Methods-54 patients with SSc (both limited and diffuse disease) and 43 unaffected control subjects of similar age and sex were recruited. All subjects underwent a basic screen for conventional atherosclerotic disease risk factors. All had non-invasive vascular assessments-that is, carotid duplex scanning and measurement of ankle brachial blood pressure index-to identify the presence of asymptomatic peripheral vascular disease. Results-33 of 52 (64%) patients had carotid artery disease compared with only 15 of 42 (35%) controls (p = 0.007). Eleven (21%) of these patients had moderate disease compared with only two (5%) controls (NS). Nine of 53 (17%) SSc patients had evidence of peripheral arterial disease compared with no controls. This result was also statistically significant (p = 0.003). There were no significant differences in the basic risk factor profile, which included cigarette smoking, systolic and diastolic blood pressure, cholesterol, trigyceride and glucose concentrations. Conclusion-Macrovascular disease is more common in SSc. Screening of these patients may allow identification of "at risk" patients at an early stage and allow the study of treatments to attenuate the high rate of cardiovascular mortality in these patients.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 36 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]  
ANTONOVYCH T T, 1962, Georgetown Med Bull, V16, P27
[3]  
*APT COLL, 1988, BRIT MED J, V296, P320
[4]  
Belch JF, 1990, VASC MED REV, V1, P203
[5]   VASCULAR DAMAGE AND FACTOR-VIII-RELATED ANTIGEN IN THE RHEUMATIC DISEASES [J].
BELCH, JJF ;
ZOMA, AA ;
RICHARDS, IM ;
MCLAUGHLIN, K ;
FORBES, CD ;
STURROCK, RD .
RHEUMATOLOGY INTERNATIONAL, 1987, 7 (03) :107-111
[6]  
BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473
[7]   INCREASED SUSCEPTIBILITY TO OXIDATION OF LOW-DENSITY LIPOPROTEINS ISOLATED FROM PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
BRUCKDORFER, KR ;
HILLARY, JB ;
BUNCE, T ;
VANCHEESWARAN, R ;
BLACK, CM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (08) :1060-1067
[8]  
Bryan C, 1996, BRIT J RHEUMATOL, V35, P1122
[9]   PATHOLOGIC OBSERVATIONS IN SYSTEMIC SCLEROSIS (SCLERODERMA) - A STUDY OF 58 AUTOPSY CASES AND 58 MATCHED CONTROLS [J].
DANGELO, WA ;
FRIES, JF ;
MASI, AT ;
SHULMAN, LE .
AMERICAN JOURNAL OF MEDICINE, 1969, 46 (03) :428-+
[10]   MEDICAL-TREATMENT OF PERIPHERAL VASCULAR-DISEASE - GOOD OR BAD [J].
DUPREZ, D ;
CLEMENT, DL .
EUROPEAN HEART JOURNAL, 1992, 13 (02) :149-151